Dr Reddy's Laboratories Return on Investment 2010-2024 | RDY

Current and historical return on investment (ROI) values for Dr Reddy's Laboratories (RDY) over the last 10 years.
Dr Reddy's Laboratories ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-09-30 $0.81B $3.78B 22.83%
2024-06-30 $0.81B $3.61B 24.13%
2024-03-31 $0.81B $3.44B 25.17%
2023-12-31 $0.78B $3.29B 25.26%
2023-09-30 $0.77B $3.12B 26.34%
2023-06-30 $0.76B $3.05B 27.21%
2023-03-31 $0.70B $2.83B 26.17%
2022-12-31 $0.57B $2.68B 21.84%
2022-09-30 $0.49B $2.56B 19.04%
2022-06-30 $0.45B $2.56B 17.55%
2022-03-31 $0.39B $2.59B 15.20%
2021-12-31 $0.49B $2.64B 19.15%
2021-09-30 $0.47B $2.56B 19.06%
2021-06-30 $0.43B $2.48B 17.81%
2021-03-31 $0.45B $2.45B 19.04%
2020-12-31 $0.46B $2.41B 20.10%
2020-09-30 $0.45B $2.34B 20.40%
2020-06-30 $0.43B $2.23B 19.41%
2020-03-31 $0.44B $2.07B 19.49%
2019-12-31 $0.41B $2.10B 17.61%
2019-09-30 $0.38B $2.39B 16.24%
2019-06-30 $0.35B $2.36B 15.21%
2019-03-31 $0.30B $2.35B 13.23%
2018-12-31 $0.26B $2.31B 11.42%
2018-09-30 $0.26B $2.19B 11.31%
2018-06-30 $0.25B $2.29B 10.67%
2018-03-31 $0.18B $2.33B 7.97%
2017-12-31 $0.20B $2.32B 8.94%
2017-09-30 $0.21B $2.25B 9.76%
2017-06-30 $0.20B $2.29B 9.80%
2017-03-31 $0.21B $2.00B 10.94%
2016-12-31 $0.22B $1.87B 11.47%
2016-09-30 $0.25B $1.89B 12.64%
2016-06-30 $0.34B $1.85B 17.00%
2016-03-31 $0.45B $2.10B 21.59%
2015-12-31 $0.51B $2.11B 24.93%
2015-09-30 $0.51B $2.02B 25.48%
2015-06-30 $0.46B $2.06B 23.16%
2015-03-31 $0.44B $2.02B 22.67%
2014-12-31 $0.40B $1.93B 20.83%
2014-09-30 $0.41B $1.89B 22.09%
2014-06-30 $0.44B $1.93B 24.44%
2014-03-31 $0.40B $1.86B 23.60%
2013-12-31 $0.41B $1.75B 25.38%
2013-09-30 $0.36B $1.65B 22.71%
2013-06-30 $0.35B $1.49B 22.89%
2013-03-31 $0.36B $1.57B 23.76%
2012-12-31 $0.42B $1.56B 28.52%
2012-09-30 $0.49B $1.51B 34.57%
2012-06-30 $0.42B $1.39B 32.02%
2012-03-31 $0.41B $1.45B 32.79%
2011-12-31 $0.29B $1.30B 24.42%
2011-09-30 $0.21B $1.09B 18.53%
2011-06-30 $0.25B $1.22B 22.73%
2011-03-31 $0.24B $1.15B 22.35%
2010-12-31 $0.19B $1.08B 17.46%
2010-09-30 $0.18B $1.02B 17.02%
2010-06-30 $0.15B $1.06B 13.56%
2010-03-31 $0.16B $1.08B 14.81%
2009-12-31 $0.37B $1.02B 34.06%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $11.978B $3.350B
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00